VLON News and Press, Vallon Pharmaceuticals Inc. From 12/10/21

Gainers: Petros Pharmaceuticals (NASDAQ:PTPI) +37%, Biofrontera BFRI +20%, ABVC BioPharma (NASDAQ:ABVC) +12%, Halozyme Therapeutics (NASDAQ:HALO) +11%, Context Therapeutics CNTX +9%. Losers: Angion Biomedica (NASDAQ:ANGN) -22%, Ensysce Biosciences ...

Gainers: Biofrontera (NASDAQ:BFRI) +154%. Longeveron (NASDAQ:LGVN) +79%. Ocuphire Pharma (NASDAQ:OCUP) +36%. Society Pass (NASDAQ:SOPA) +24%. Biofrontera (NASDAQ:BFRA) +23%. Better Therapeutics (NASDAQ:BTTX) +20%. Applied UV (NASDAQ:AUVI) +19%. Standard Lithium (NYSE:SLI) +19%. Blue Star Food...

Gainers: Biofrontera (NASDAQ:BFRI) +109%, Longeveron (NASDAQ:LGVN) +87%, Ocuphire Pharma (NASDAQ:OCUP) +41%, Better Therapeutics (NASDAQ:BTTX) +24%, Reviva Pharmaceuticals (NASDAQ:RVPH) +12%. Losers: Vallon Pharmaceuticals (NASDAQ:VLON) -34%, Pasithea Therap...

The hunt to find the best penny stocks to buy can be complicated at times. Thanks to the rise of the retail trader, there’s a lot of noise to sift through. Do you follow that random Twitter account that seems to be “right” about a stock that is already heavily discussed...

Vallon Pharmaceuticals (NASDAQ:VLON): Q3 Net loss of $1.3M. As of September 30, 2021, the Company had cash, cash equivalents and marketable securities of approximately $9.1 million, which the Company expects will provide funding for its ongoing development and business activities into the thi...

- Ongoing pivotal intranasal abuse study of l ead program, ADAIR, advancing toward completion of patient enrollment and treatment in Q1 2022 - Advancement of second development program, ADMIR, with s election of final formulation completed ...

- Live moderated video webcast discussion among members of management and ADHD and a buse e xpert, Stephen V. Faraone, Ph.D., on T hurs day, November 18 th at 3 :00 P M ET PHILADELPHIA, PA, Nov. 11, 2021 (GL...

- Live video webcast presentation on Monday, November 15 th at 8:30 am ET PHILADELPHIA, PA, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutica...

- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast roundtable discussions with members of Management and Thought Leaders across participating companies - PITTSTOWN, NJ / ACCESSWIRE / November 4, 2021 / November 4, 2021 -...

- Results suggest that developing stimulant formulations with abuse deterrent properties by non-oral routes may potentially reduce negative consequences of misuse, abuse, and diversion of stimulant medication - Company’s l ead investigational program...